Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome

乳腺癌进展过程中,癌相关成纤维细胞的组成发生变化,S100A4+和PDPN+ CAFs的比例与临床结果相关。

阅读:7
作者:Gil Friedman ,Oshrat Levi-Galibov ,Eyal David ,Chamutal Bornstein ,Amir Giladi ,Maya Dadiani ,Avi Mayo ,Coral Halperin ,Meirav Pevsner-Fischer ,Hagar Lavon ,Shimrit Mayer ,Reinat Nevo ,Yaniv Stein ,Nora Balint-Lahat ,Iris Barshack ,H Raza Ali ,Carlos Caldas ,Einav Nili-Gal-Yam ,Uri Alon ,Ido Amit ,Ruth Scherz-Shouval

Abstract

Tumors are supported by cancer-associated fibroblasts (CAFs). CAFs are heterogeneous and carry out distinct cancer-associated functions. Understanding the full repertoire of CAFs and their dynamic changes as tumors evolve could improve the precision of cancer treatment. Here we comprehensively analyze CAFs using index and transcriptional single-cell sorting at several time points along breast tumor progression in mice, uncovering distinct subpopulations. Notably, the transcriptional programs of these subpopulations change over time and in metastases, transitioning from an immunoregulatory program to wound-healing and antigen-presentation programs, indicating that CAFs and their functions are dynamic. Two main CAF subpopulations are also found in human breast tumors, where their ratio is associated with disease outcome across subtypes and is particularly correlated with BRCA mutations in triple-negative breast cancer. These findings indicate that the repertoire of CAF changes over time in breast cancer progression, with direct clinical implications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。